ESC congress returns to London

Br J Cardiol 2017;24:135 Leave a comment
Click any image to enlarge

The ESC decision is a huge vote of confidence in London as a leading centre for medical research. London overcame stiff competition from other key European cities in winning the event for 2021. When the ESC last came to London in 2015, it generated £100 million of economic benefit for the city, attracting more than 32,700 delegates from 140 countries.

ESC 2021 London announcement

The decision to stage the congress in London comes as the Mayor, Sadiq Khan, adopted the Healthy Streets Approach, prioritising health in transport and planning decisions, and investing £2.1 billion into street schemes that promote walking, cycling and public transport over private car use. Analysis from the Mayor’s office shows that if every Londoner walked or cycled for 20 minutes a day, it would save the National Health Service £1.7 billion in treatment costs over the next 25 years and result in 16,400 fewer cases of heart disease.

Reports from ESC 2017

More news in this issue:

NICE publishes updated familial hypercholesterolaemia guidance

REDUCE shows non-inferiority of short versus long DAPT in acute coronary syndrome

Primary Care Cardiovascular Society announces its relaunch

New series on insights from the Bradford Healthy Hearts project

Cardiff Met launches stroke research hub

New test hopes to boost med school recruitment

Rivaroxaban label update for extended VTE prevention

Anticoagulation group rebrands and partners with the BJC